Notice: Release of draft revised guidance documents on Post-Notice of Compliance (NOC) Changes – Quality, for stakeholder consultation

Notice: Release of draft revised guidance documents on Post-Notice of Compliance (NOC) Changes – Quality, for stakeholder consultation Health Canada is pleased to announce the release of five associated revised draft guidance documents on Post-Notice of Compliance (NOC) Quality Changes for pharmaceutical, biologic and radiopharmaceutical drugs for human use, for stakeholder consultation. 2021-12-29 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetydraft revised guidancepost-notice of compliancechanges for pharmaceuticalchanges for biologicchanges for radiopharmaceuticaldrugs for human-usefor stakeholder consultation Notice: Release of draft revised guidance documents on Post-Notice of Compliance (NOC) Changes – Quality, for stakeholder consultationHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-release-draft-revised-guidance-documents-post-notice-compliance-changes-quality.html Notice: Release of draft revised guidance documents on Post-Notice of Compliance (NOC) Changes – Quality, for stakeholder consultationHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/avis-publication-ebauches-revisees-lignes-directrices-changements-survenus-apres-avis-conformite-document-qualite.html

Health Canada is pleased to announce the release of five associated revised draft guidance documents on Post-Notice of Compliance (NOC) Quality Changes for pharmaceutical, biologic and radiopharmaceutical drugs for human use, for stakeholder consultation.

Data and Resources

Similar records